Indication: Tavaborole (Kerydin) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.

Insight:

Dosing: Apply tavaboroleto affected toenails once daily for 48 weeks.
Dosage forms:Solution, 5%.
Adverse events: Common adverse reactions occurring in ≥1% in subjects treated with tavaboroleincluded application site exfoliation, ingrown toenail, application site erythema, and application site dermatitis.
Mechanism of action: Kerydin is an oxaborole antifungal.
Manufacturer: Anacor Pharma

Sources:

LABEL (fda.gov)
kerydin image - Google Search